Early studies evaluating the role of 17-hydroxyprogesterone (17-OHP) in male reproduction were primarily conducted in fertile men receiving exogenous testosterone with varying doses of human chorionic gonadotropin (hCG). However, few studies have investigated 17-OHP within the context of true male infertility. Although higher 17-OHP levels might intuitively be expected to reflect greater steroidogenic activity, the only prior study in infertile men paradoxically found that elevated 17-OHP was associated with more severe infertility. In this study, we obtained comprehensive steroidogenesis profiles in men presenting for infertility evaluation to assess the relationship between steroidogenesis component and infertility.
METHODS:
Men presenting to an academic andrology clinic for infertility evaluation were retrospectively reviewed. Subjects were stratified by the ratio of 17-hydroxypregnenolone to 17-hydroxyprogesterone (17OHPreg:17OHP) and divided into tertiles. Comparisons were made between men in the lowest and highest tertiles. All laboratory samples were obtained before 1:00 PM to minimize diurnal variation. Laboratory parameters were compared using the Mann–Whitney U test.
RESULTS:
Forty-nine men completed steroidogenesis evaluation. The median 17OHPreg:17OHP ratio for the cohort was 1.88 (1.04–2.55). Men in the highest tertile demonstrated a median ratio of 2.50 (1.99–2.58), compared to 1.02 (0.75–1.23) in the lowest tertile. While men in the lowest tertile exhibited higher absolute 17-OHP levels, no other hormonal parameters differed significantly between groups. Importantly, men with a lower 17OHPreg:17OHP ratio had significantly lower total motile sperm counts, suggesting a negative association between elevated 17-OHP and spermatogenic output.
CONCLUSIONS:
Among men presenting with infertility, higher 17-OHP levels were inversely associated with total motile sperm count. These findings indicate that elevated 17-OHP may reflect impaired steroidogenic efficiency or dysregulation within the 17-hydroxylase pathway. Further investigation is warranted to clarify the mechanistic and diagnostic role of 17-OHP in the evaluation of male infertility.
* Human chorionic gonadotropin (hCG) therapy can be co-administered with TTh to maintain spermatogenesis, testicular size, or libido, but no study has assessed associated 17-OHP levels in these men on concurrent TTh and hCG therapy. levels in men on TTh.
* In our practice, hCG 1500 IU subcutaneous injection is prescribed once weekly to maintain spermatogenesis while on TTh, 1500 IU twice weekly to restore testicular size or improve libido while on TTh, or 3000 IU three times weekly plus FSH and TTh when attempting to reboot spermatogenesis after TTh therapy allowing...
The use of testosterone replacement therapy (TRT) increases blood levels of testosterone but, surprisingly, it decreases the level of testosterone inside the testicles (Intratesticular testosterone or ITT). ITT is key for proper sperm production. This ITT decrease is due to the LH and FSH shut down that occurs with TRT. This shut down decreases ITT and sperm production in men on TRT. These two gonadotropins are required to maintain healthy levels of ITT and, thus, sperm production. Some men on TRT become infertile because of this issue. ITT levels are usually ten times higher than...
ExcelMale Newsletter Signup
Stay Informed with Our Newsletter
Get the latest men's health insights, expert advice, and community updates delivered to your inbox.